C. Scaglioni-Weinlich

发表

Oral GS-5806 activity in a respiratory syncytial virus challenge study.

Rob Lambkin-Williams, S. Lewis, R. Jordan, 2014, The New England journal of medicine.

LB-1Treatment with Oral ALS-008176, a Nucleoside Analog, Rapidly Reduces RSV Viral Load and Clinical Disease Severity in a Healthy Volunteer Challenge Study

Rob Lambkin-Williams, Qingling Zhang, J. Symons, 2014 .